| Triple-Negative Breast Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 143show all (up to 200) |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 140 trials (76 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 140 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall_molecule 102 trials (52 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 102 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 93 trials (46 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 93 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 70 trials (33 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 58 trials (24 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 45 trials (23 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 39 trials (18 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall_molecule 33 trials (14 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 32 trials (23 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal_antibody 26 trials (7 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall_molecule 21 trials (7 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 21 trials (11 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall_molecule 21 trials (11 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 20 trials (10 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall_molecule 20 trials (8 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 20 | Observed | clinicaltrials | graph → |